Honda robot aids young cancer patients during extended treatment

The intersection of healthcare and artificial intelligence is taking a compassionate turn as Honda deploys an AI-powered robot to support young cancer patients during their treatment journey.

Program Overview: Honda’s Research Institute Japan has developed Haru, an AI-driven “social bot” that is helping children undergoing cancer treatment at Spain’s Virgen del Rocio hospital.

• The program began trials in 2021 and has proven so successful that the hospital is expanding its deployment with 10 additional units through 2027
• Haru stands 11 inches tall and resembles a desktop companion with two small screens that serve as “eyes” and LED lights forming a “mouth”
• The robot connects patients with their schools online, enabling them to maintain social connections and continue their education during treatment

Technical Capabilities: Haru employs sophisticated AI and sensing technologies to provide personalized emotional support to young patients.

• The robot uses built-in cameras and microphones to analyze facial expressions and voice tones, helping it understand patients’ emotional states
• An optional wearable wristband provides additional data about the patient’s condition
• Based on its analysis, Haru responds with empathetic expressions and supportive language tailored to each child’s needs

Healthcare Impact: The implementation of Haru has shown significant potential for improving both emotional support and clinical assessment capabilities.

• Neuropsychologists at the hospital can now conduct more frequent emotional and cognitive assessments, potentially increasing annual evaluations from 510 to 4,500
• Hospital staff report that Haru provides psychological benefits by improving patients’ moods during treatment
• The technology represents a shift from purely medical applications to addressing the emotional well-being of patients

Future Implications: Honda’s development of Haru demonstrates how AI and robotics can be integrated into healthcare settings to provide both practical and emotional support.

• Honda’s research team continues to refine Haru’s capabilities, working toward 24/7 assistance for patients and hospital staff
• The success of this program could pave the way for similar AI-powered emotional support systems in other healthcare settings
• This application shows how AI can complement, rather than replace, human care in sensitive medical environments

Long-term Potential: While the immediate benefits of Haru are evident in pediatric oncology, this implementation may represent just the beginning of AI-powered emotional support systems in healthcare, particularly in situations requiring extended hospital stays or chronic condition management.